Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04230512 · ClinicalTrials.gov registry record · NA

Hybrid Pump Technology

A NA study of Amputation, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04230512 is a NA study of Amputation that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 20 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04230512, a NA study of Amputation, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Prostheses can be suspended from the amputated limb using a variety of techniques, such as straps and suction. Suspending the prosthesis by creating a vacuum between the prosthetic socket and limb using a pump has benefits over other techniques including improved limb health and mobility. A new pump design will be tested by prosthesis users in the laboratory to verify its functionality during walking.

Conditions Studied

Interventions

  • OTHER Pump prototype

Study Locations (1)

Illinois

  • Jesse Brown VA Medical Center, Chicago, IL - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-04-04
Est. Completion 2026-03-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT04230512

The ClinicalTrials.gov registry entry for NCT04230512 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (85% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which Pump prototype is the first listed.

NCT04230512 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04230512 about?

NCT04230512 is a clinical study titled "Hybrid Pump Technology". Prostheses can be suspended from the amputated limb using a variety of techniques, such as straps and suction. Suspending the prosthesis by creating a vacuum between the prosthetic socket and limb using a pump has benefits over other techniques including improved limb health and mobility. A new pump...

What is the current status of trial NCT04230512?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2020-04-04. Estimated completion is 2026-03-31.

What conditions does trial NCT04230512 study?

This clinical trial studies the following conditions: Amputation.

What interventions are being tested in trial NCT04230512?

The interventions under investigation include: Pump prototype (OTHER).

Who is sponsoring clinical trial NCT04230512?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04230512 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.